CEO of Anika Therapeutics
CEO of Anika Therapeutics
Current Market Cap
$252.68M
Number of Employees
357
No compensation data available for Stephen Griffin yet. Come back soon!
Stephen Griffin
CEO of Anika Therapeutics
Education
Field of Expertise
Born
Invalid Date - 0 years ago
Is Founder?
No
Current Tenure
0 years 5 months (Jun 2024 - Present)
Previous Experience
Unknown
Predecessor
Michael Levitz
July 2020 - May 2024
Successor
None